Question 1

What is the catalog number for CD205 (Renal Cell Carcinoma, gp200-MR6, CD205, CLEC13B, DEC-205, gp200 MR6, Lymphocyte Antigen 75, LY75, Podocalyxin) discontinued?

Accepted Answer

The catalog number for CD205 (Renal Cell Carcinoma, gp200-MR6, CD205, CLEC13B, DEC-205, gp200 MR6, Lymphocyte Antigen 75, LY75, Podocalyxin) discontinued is R1450-03F.

Question 2

What sizes are available for CD205 (Renal Cell Carcinoma, gp200-MR6, CD205, CLEC13B, DEC-205, gp200 MR6, Lymphocyte Antigen 75, LY75, Podocalyxin) discontinued?

Accepted Answer

CD205 (Renal Cell Carcinoma, gp200-MR6, CD205, CLEC13B, DEC-205, gp200 MR6, Lymphocyte Antigen 75, LY75, Podocalyxin) discontinued is available in the following size(s): 200 µg.

Question 3

Is CD205 (Renal Cell Carcinoma, gp200-MR6, CD205, CLEC13B, DEC-205, gp200 MR6, Lymphocyte Antigen 75, LY75, Podocalyxin) discontinued in stock?

Accepted Answer

CD205 (Renal Cell Carcinoma, gp200-MR6, CD205, CLEC13B, DEC-205, gp200 MR6, Lymphocyte Antigen 75, LY75, Podocalyxin) discontinued

Selected Variant

R1450-03F

Size: 200 µg

Product Specifications

Clonality

Mab

Question 4

Can this product be used for co-immunoprecipitation (Co-IP)?

Accepted Answer

Suitability for Co-IP depends on the specific antibody and is noted under validated applications on the datasheet. If it isn’t listed, contact our technical support team for guidance based on your target and sample type.

Question 5

Is this kit compatible with automated liquid handling platforms?

Accepted Answer

Automation compatibility varies by kit and isn’t always listed on the datasheet. Contact our technical support team with details of your platform so we can confirm with the manufacturer.

Question 6

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.